DLA Piper advised Axsome Therapeutics on the deal. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
DLA Piper advised Axsome Therapeutics on the deal. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...